Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Opioid Training Initiative: Outpatient Focus


Doctor taking vitals
 

Opioid Training Initiative: Outpatient Focus

 
This Opioid Training Initiative course was developed to train healthcare professionals who work primarily in outpatient settings, how to identify opioid use disorder (OUD), understand harm reduction best practices, implement safe and effective pain management interventions, use the prescription monitoring program (PMP), and discuss concerns about drug misuse with patients.
 
This course includes four unique one hour video modules, each covering a key topic. Healthcare professionals are welcome to take one or all of the modules based on their professional need, but are encouraged to complete all modules to gain a full conceptual understanding of the topic. The information in this course has been specifically tailored to meet the needs of clinicians practicing in Texas with a focus on regional trends, laws and regulations.

Modules

The following modules are included in this course.  See the tabs below for more information on each module, and, once registered, for access to the module content.

  1. From Survival to Recovery in Opioid Use Disorder
  2. Harm Reduction Basics for Healthcare Professionals
  3. Pain, Opioids and Choices: when Tapering and Safety Collide
  4. Effective Use of the Prescription Monitoring Program

Format

Each module consists of an MP4 format video along with presentation slides in PDF format. Some modules include links to referenced programs and additional resources. Videos appear in the modules tabs below after registration. Learners may take one or all of the modules. CE credit is awarded upon completion of the evaluation. Credit accumulates as modules are completed. For pharmacy CPE, credits will be awarded to the NABP eprofile of the learner. For all others, once you complete each module, credit is added to the certificate. Click on the link at the top of the page "View/Print CE Credit".  This certificate remains available in the learner's profile.  Bookmark this page for easy return access while working through the various modules.  At anytime, please feel free to email the UT College of Pharmacy Continuing Education Office at UTpharmacyCE@austin.utexas.edu for assistance.

Faculty

Special thank you to the following faculty who developed the content of this course.  Additional biography and disclosure information is available in the module tabs.

 
  • Lucas G. Hill, PharmD, BCPS, BCACP • Clinical Assistant Professor, Director of Pharmacy Addictions Research & Medicine (PhARM) Program, The University of Texas at Austin College of Pharmacy
  • Claire Zagorski, MSc, LP •  Program Coordinator and Harm Reduction Instructor, Director, Longhorn Stop the Bleed, The University of Texas at Austin College of Pharmacy
  • Stefan G. Kertesz, MD, MSc, FASAM • Professor of Medicine, University of Alabama at Birmingham, Physician, Birmingham Veterans Affairs Medical Center
  • Marc Fleming, PhD, MPH, RPh • Associate Professor and Chair of Pharmacotherapy, University of North Texas College of Pharmacy
  • Ashley (Kristin) Garling, Pharm.D. Clinical Assistant Professor of Pharmacy Practice, The University of Texas at Austin College of Pharmacy

Continuing Education Information

Please Note:  Modules that discuss specific CE subject requirements will be labeled as such in their activity description.

 
ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.4 CEUs (4.00 contact hours) of continuing education credit. In order to receive 4.00 contact hours of CE credit, the participant must watch all videos in their entirety, complete the online post-tests, and complete online evaluations. Credit will be awarded per module completed.  Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system. 


The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Long School of Medicine designates this material for a maximum of 4.0 AMA PRA Category 1 Credit™


The University of Texas at Austin School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. For information on CNE requirements and conflict of interest, please see the full Continuing Nursing Education disclosures for these courses here. Please note that the CNE on these courses expires August 26, 2022.


The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work is accredited by the Council on Social Work Education, and as such receives automatic approval as a continuing education provider by the Texas Board of Social Work Examiners under Texas Administrative Code, Title 22, Part 34. § 781.511(c). The program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists.  Please note that 1 hour = 1 CEU.  Complaints about this program may be made to TSBSWE  333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701  •  512-305-7700 • 800-821-3205 •

This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Fee

$0.00

CE Hours

4.00

CE Units

0.400

Activity Type

  • Knowledge

Target Audience(s)

  • Advance Practice Nurses (CME)
  • Counselors
  • Nurse Practitoners (CME)
  • Nurses
  • Pharmacists
  • Pharmacy Technicians
  • Physician Assistant
  • Physicians
  • Psychologists
  • Social Workers

 

 

   

 

From Survival to Recovery in Opioid Use Disorder

 
Lucas G. Hill, PharmD, BCPS, BCACP
Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy
Director, Pharmacy Addictions Research & Medicine (PhARM) Program
 
 

In this module, Dr. Hill describes best practices for opioid overdose prevention, compares FDA-approved medications for opioid use disorder and discusses current controversies and ethical issues in opioid use disorder treatment.  

 

FACULTY

Lucas G. Hill, PharmD, BCPS, BCACP, graduated from the University of Missouri-Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship in the University of Pittsburgh Medical Center St. Margaret Department of Family Medicine. He is now a clinical assistant professor at The University of Texas at Austin (UT) College of Pharmacy. Dr. Hill is the director and principal investigator of Operation Naloxone, an interprofessional opioid overdose prevention program funded through the Texas Targeted Opioid Response. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies. Dr. Hill coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and serves as lead instructor for a module that trains students from pharmacy, medicine, nursing, and social work to provide team-based care for patients with addiction. He provides an additional 16 hours of addiction-related instruction in the required pharmacy curriculum and precepts both the overdose prevention introductory pharmacy practice experience and the addiction medicine advanced pharmacy practice experience. Dr. Hill currently serves as chair-elect of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. He is also faculty advisor for the UT Student Pharmacist Recovery Network and co-chair for the UT Opioid Response Consortium. In 2020, Dr. Hill was awarded the American Pharmacists Association Generation Rx Award of Excellence in recognition of his outstanding contributions to addiction-related education.

 

DISCLOSURE: Dr. Hill receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services Commission via the Texas Targeted Opioid Response.

 

LEARNING OBJECTIVES

  • Describe best practices for opioid overdose prevention
  • Compare FDA-approved medications for opioid use disorder
  • Discuss current controversies and ethical issues in opioid use disorder treatment
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Activity Number

0067-9999-20-096-H08-P/T

Release Date: Aug 1, 2020
Credit Expiration Date: Aug 1, 2022

CE Hours

1.00
   

   

 

Harm Reduction Basics for Healthcare Professionals

 
Claire Zagorski, MSc, LP
Program Coordinator and Harm Reduction Instructor,
Director, Longhorn Stop the Bleed
College of Pharmacy
Dell Medical School
The University of Texas at Austin
 
 

In this module, Claire Zagorski describes the fundamentals of harm reduction, reviews the historical and modern-day context surrounding drug use in the United States, and describes the three ways of the current opioid crisis. Illicit drug use is a reality.  It has been present throughout history.  There are very real and significant dangers directly associated with illicit drug use as known today.  Harm reduction can be adapted to reflect specific needs of both individuals and the community.  In this module, various strategies of harm reduction are discussed, including stigma reduction, reducing chances of withdrawal in the hospital setting, availability of naloxone, Buprenorphine diversion and the use of person-centered motivational interviewing skills in treatment. 

 

FACULTY

Claire Zagorski is a licensed paramedic with eight years of high volume, high acuity, urban ED experience. She is the Program Coordinator and Harm Reduction Instructor for the PhARM Program at The University of Texas at Austin College of Pharmacy and Founder and Director of Longhorn Stop the Bleed, bringing simple, free and accessible trauma response training to The University of Texas at Austin community. She has seven years of hands-on experience in harm reduction practice, advocacy and research, and is the former Coordinator of the Health Leadership Apprentice Program, a student research and professional development program for future healthcare leaders at Dell Medical School. Claire is a current MScPH student at the London School of Hygiene and Tropical Medicine. She has her MS in medical sciences from The University of North Texas Health Science Center and her BA in anthropology from The University of Texas at Austin.

 

DISCLOSURE: Claire Zagorski receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services Commission via the Texas Targeted Opioid Response.

 

LEARNING OBJECTIVES

  • Describe the fundamentals of harm reduction
  • Understand the historical and modern-day context surrounding drug use in the United States
  • Compare the three waves of the opioid crisis
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Activity Number

0067-9999-20-097-H08-P/T

Release Date: Aug 1, 2020
Credit Expiration Date: Aug 1, 2022

CE Hours

1.00
   

   

 

Pain, Opioids and Choices: when Tampering and Safety Collide

 
Stefan G. Kertesz, MD, MSc, FASAM
Professor of Medicine
University of Alabama at Birmingham
Physician, Birmingham Veterans Affairs Medical Center
 
 

In this module, Dr Kertesz describes policy steps that health and other systems have taken to pivot away from prescription opioids.  He discusses how some policy actions have caused both stress and harm to patients, families, and clinicians.  The module concludes with describing preliminary efforts by some agencies to develop policies that reverse stress and harm, and provides data-driven results greatly impacting patients, families, clinicians and communities.

 

This module may be applied to specific CE requirements for Prescribing and Monitoring Controlled Substances (Board rule 295.8(d)(1)(C))  - OR -  this module may be applied to specific CE requirements for Pain Management (Board rule 295.8(d)(1)(B))  

Important Note:  Per TSBP, pharmacists may not use a single CE activity to count towards two different TSBP subject requirements.

 

FACULTY

Kertesz, certified in internal medicine and addiction medicine, has a 22-year history of delivering primary care for vulnerable populations such as the homeless, and an 18-year history of research funded by the National Institute on Drug Abuse and Veterans Administration on care and services for problems of addiction and drug use. An addiction scholar, Kertesz serves on multiple task forces and teams related to opioid safety. He also led a national petition that resulted in major changes to a planned policy set up by the Centers for Medicare and Medicaid Services.

 

DISCLOSURE: Dr. Kertesz owns shares of Thermo Fisher, CVS Health, Zimmer Biomedical. 

 

LEARNING OBJECTIVES

  • Describe policy steps that health and other systems have taken to pivot away from prescription opioids and the effect it is having on patients, families, clinicians and pharmacists.
  • Examine a full history of peripheral, central and contextual pain drivers when assessing chronic pain in patients.
  • Describe evidence that explains whether or not opioids are effective in managing long-term chronic pain. 
  • Describe whether or not opioid reduction and discontinuation under regular practice conditions is followed by safety improvement.
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Activity Number

0067-9999-20-098-H08-P/T

Release Date: Aug 1, 2020
Credit Expiration Date: Aug 1, 2022

CE Hours

1.00
   

   

Effective Use of the Prescription Monitoring Program (PMP)

 
Marc Fleming, PhD, MPH, RPh
Associate Professor and Chair of Pharmacotherapy
University of North Texas College of Pharmacy
 
Ashley (Kristin) Garling, Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
 

In this module, Dr Fleming discusses the impact of mandated Prescription Monitoring Program (PMP) use with patients and healthcare professionals.  The module discusses PMP use and results in Texas including success in shifts in pain management and coprescribing of nalxone.  Dr. Fleming discusses pain management in the age of PMP and monitoring of morphine milligram equivalents MMEs.  Dr. Garling discusses pharmacists best practices for communication with patients considering controlled substance prescription.  She also provides tips for healthcare professionals on communication with patients about PMP.

* Note:  This module discusses Prescribing and Monitoring Controlled Substances as specified by (Board rule 295.8(d)(1)(C)) 

 

FACULTY

Dr. Fleming is Associate Professor and Department Chair of Pharmacotherapy at the University of North Texas System College of Pharmacy in Fort Worth, Texas. Dr. Fleming was a practicing pharmacist for 15 years before receiving his PhD in Health Outcomes and Pharmacy Practice from The University of Texas at Austin in 2012. Dr. Fleming is currently working with Texas Health and Human Services Commission on two SAMHSA funded grants concerning prescription drug misuse and addressing the opioid crisis. He has also conducted studies assessing the utilization of the Texas prescription drug monitoring program (PDMP) among pharmacists and emergency physicians. Prior research studies include examining the impact of hydrocodone rescheduling on physician prescribing, as well as analyzing data from the Texas PDMP to identify multiple provider episodes. Dr. Fleming has presented on pharmaceutical drugs of misuse and PDMPs to numerous state and national audiences.

Dr. Ashley Garling is currently a Clinical Assistant Professor in the Pharmacy Practice Division of the University of Texas at Austin. Dr. Garling has dedicated her career to pharmacy promotion, patient engagement, and public education. Dr. Garling is fundamentally interested in the evolution of pharmacy utilizing communication and technology.

 

DISCLOSURE: Dr. Fleming has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

DISCLOSURE: Dr. Garling has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

 

LEARNING OBJECTIVES

  • Discuss the impact of mandated Prescription Monitoring Program (PMP) use
  • Debate pain management in the age of PMP and monitoring of morphine milligram equivalents (MMEs)
  • Discuss using non-stigmatized and inclusive language with patients to address common situations around controlled substances
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Activity Number

0067-9999-20-120-H08-P/T

Release Date: Aug 1, 2020
Credit Expiration Date: Aug 1, 2022

CE Hours

1.00